(Q39913801)

15 September 2017

title

Mesenchymal stem cells as trojan horses for GDNF delivery in ALS. (English)

1 reference

amyotrophic lateral sclerosis

15 September 2017

main subject

1 reference

inferred from title

mesenchymal stem cell

1 reference

Brian K Kaspar

1

1 reference

15 September 2017

publication date

1 December 2008

1 reference

15 September 2017

1 reference

15 September 2017

volume

16

1 reference

15 September 2017

issue

12

1 reference

15 September 2017

page(s)

1905-1906

1 reference

From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.216

7 January 2021

Amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.216

7 January 2021

Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.216

7 January 2021

ALS: a disease of motor neurons and their nonneuronal neighbors

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.216

7 January 2021

Onset and progression in inherited ALS determined by motor neurons and microglia

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.216

7 January 2021

Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.216

7 January 2021

Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.216

7 January 2021

Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.216

7 January 2021

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.216

7 January 2021

Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.216

7 January 2021

GDNF delivery using human neural progenitor cells in a rat model of ALS.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.216

7 January 2021

GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.216

7 January 2021

Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.216

7 January 2021

Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.216

7 January 2021

Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.216

7 January 2021

Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.216

7 January 2021

Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.216

7 January 2021

Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.216

7 January 2021

Identifiers

DOI

10.1038/MT.2008.216

1 reference

15 September 2017

1 reference